We have observed
5 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 18, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
RHAMM BINDING PEPTIDES
Improved cholagogue compositions for treating biliary and digestive tract discomfort
STERILE AND INSTANTLY DISSOLVABLE DRUG MEMBRANE AND USE THEREOF FOR TESTING TUMOR DRUG SENSITIVITY
DETECTION OF PROTEIN TO PROTEIN INTERACTIONS
CATALYTIC NUCLEIC ACID AND GOLD NANOPARTICLES FOR DETECTION OF BIOMOLECULES